17 α-Hydroxyprogesterone caproate (Makena™): in the prevention of preterm birth.
about
The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth.17 α-hydroxyprogesterone caproate (Makena®): a guide to its use in the prevention of preterm birth.Agonist-Dependent Downregulation of Progesterone Receptors in Human Cervical Stromal Fibroblasts.
P2860
17 α-Hydroxyprogesterone caproate (Makena™): in the prevention of preterm birth.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
17 α-Hydroxyprogesterone caproate (Makena™): in the prevention of preterm birth.
@en
17 α-Hydroxyprogesterone caproate
@nl
type
label
17 α-Hydroxyprogesterone caproate (Makena™): in the prevention of preterm birth.
@en
17 α-Hydroxyprogesterone caproate
@nl
prefLabel
17 α-Hydroxyprogesterone caproate (Makena™): in the prevention of preterm birth.
@en
17 α-Hydroxyprogesterone caproate
@nl
P2860
P1433
P1476
17 α-Hydroxyprogesterone caproate (Makena™): in the prevention of preterm birth.
@en
P2093
Emma D Deeks
P2860
P304
P356
10.2165/11208140-000000000-00000
P577
2011-10-01T00:00:00Z
P6179
1003435132